Kimberly Lee | SVP, Corporate Communications & IR |
RA Session II | President, CEO & Founder |
Suyash Prasad | CMO & Head, R&D |
Kamran Alam | CFO |
Joon Lee | Truist Securities |
Gil Blum | Needham and Company |
Laura Chico | Wedbush Securities |
Elizabeth Webster | Goldman Sachs |
Mike Ulz | Morgan Stanley |
Kevin DeGeeter | Oppenheimer |
Yun Zhong | BTIG |
Kristen Kluska | Cantor Fitzgerald |
Raju Prasad | William Blair |
Silvan Tuerkcan | JMP Securities |
Welcome to the Taysha Gene Therapies Third Quarter 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.
Following management's prepared remarks; we will hold a brief question-and-answer session.
As a reminder, this call is being recorded today, November 10, 2021. I will now turn the call over to Dr.